Veraxa Biotech AG Company Profile
NASDAQ: VRXAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.20+0.12 (+11.11%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 1.22 +1.67%
Veraxa Biotech at a glance
Veraxa Biotech AG (NASDAQ: VRXA) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector. At a market capitalization of $152.7 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0002079109, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
Company information
- Legal name
- Veraxa Biotech AG
- Ticker
- NASDAQ: VRXA
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Headquarters
- Switzerland
- Market cap
- $152.72M
- SEC CIK
- 0002079109
Companies similar to Veraxa Biotech
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| KRROKorro Bio Inc. | 10.49 | +7.48% | $154.47M | vs VRXA |
| NERVMinerva Neurosciences Inc | 3.27 | -4.66% | $156.13M | vs VRXA |
| ALXOALX Oncology Holdings Inc. | 1.13 | +1.80% | $156.25M | vs VRXA |
| MENSJyong Biotech Ltd. | 2.06 | +1.98% | $156.62M | vs VRXA |
| NBPNovaBridge Biosciences ADR | 1.37 | -2.14% | $158.92M | vs VRXA |
| SDEVStablecoin Development Corporation | 2.78 | -14.46% | $143.87M | vs VRXA |
| MSLESatellos Bioscience Inc. | 7.63 | +1.19% | $161.88M | vs VRXA |
| EMISEmmis Acquisition Corp. Class A | 10.27 | 0.00% | $162.02M | vs VRXA |